William Mcdowall Wells - Net Worth and Insider Trading

William Mcdowall Wells Net Worth

The estimated net worth of William Mcdowall Wells is at least $684,750 dollars as of 2024-11-13. William Mcdowall Wells is the Director of Bausch Health Companies Inc and owns about 75,000 shares of Bausch Health Companies Inc (BHC) stock worth over $684,750. Details can be seen in William Mcdowall Wells's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Mcdowall Wells has not made any transactions after 2010-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of William Mcdowall Wells

To

William Mcdowall Wells Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William Mcdowall Wells owns 2 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) , and Bausch Health Companies Inc (BHC) .

Click here to see the complete history of William Mcdowall Wells’s form 4 insider trades.

Insider Ownership Summary of William Mcdowall Wells

Ticker Comapny Transaction Date Type of Owner
ACAD ACADIA Pharmaceuticals Inc 2012-01-27 director
BHC Bausch Health Companies Inc 2010-12-07 director & Chief Executive Officer

William Mcdowall Wells Latest Holdings Summary

William Mcdowall Wells currently owns a total of 1 stock. William Mcdowall Wells owns 75,000 shares of Bausch Health Companies Inc (BHC) as of December 7, 2010, with a value of $684,750.

Latest Holdings of William Mcdowall Wells

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHC Bausch Health Companies Inc 2010-12-07 75,000 9.13 684,750

Holding Weightings of William Mcdowall Wells


William Mcdowall Wells Form 4 Trading Tracker

According to the SEC Form 4 filings, William Mcdowall Wells has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the sale of 507,851 shares on December 7, 2010, which brought William Mcdowall Wells around $14 Million.

Insider Trading History of William Mcdowall Wells

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William Mcdowall Wells Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

William Mcdowall Wells Ownership Network

Ownership Network List of William Mcdowall Wells

No Data

Ownership Network Relation of William Mcdowall Wells

Insider Network Chart

William Mcdowall Wells Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

William Mcdowall Wells is the director of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, William Mcdowall Wells made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

William Mcdowall Wells Mailing Address

Above is the net worth, insider trading, and ownership report for William Mcdowall Wells. You might contact William Mcdowall Wells via mailing address: Ocean One, Unit 304, Maxwell Coast Road, Oistins C8 Bb17154.